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This review, dedicated to the memory of Professor Setsuro Ebashi, focuses on our current work investigating the cellular functions
and regulation of the unique unconventional motor, myosin VI. This myosin, unlike all the other myosins so far studied, moves towards
the minus end of actin ﬁlaments and has been implicated in a wide range of cellular processes such as endocytosis, exocytosis, cell migra-
tion, cell division and cytokinesis. Myosin VI’s involvement in these cellular pathways is mediated by its interaction with speciﬁc adaptor
proteins and is regulated by multiple regulatory signals and modiﬁcations such as calcium ions, PtdIns(4,5)P2 (PIP2) and phosphoryla-
tion. Understanding the functions of myosin VI within the cell and how it is regulated is now of utmost importance given the recent
observations that it is associated with a number of human disorders such as deafness and cancers.
 2007 Elsevier Inc.
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Open access under CC BY license.Our review is dedicated to the memory of Professor
Setsuro Ebashi and his pioneering work on the fundamen-
tal role of calcium ions as a cellular signal and regulator of
intracellular processes, which has had such a profound
inﬂuence on our understanding of the regulation of muscu-
lar contraction. We would like to start by brieﬂy introduc-
ing what we believe are a few of the major milestones in the
discovery of the mechanisms involved in regulating con-
tractile activity in cells. We will focus mainly on myosin
linked regulatory systems ﬁrst in muscle and then in cells
in general focusing on our current work investigating
how the functions of an unconventional myosin (myosin
VI) may be regulated in non-muscle cells. Our selected
milestones are the following:
(1) Almost forty years ago in 1968 Professors Setsuro
Ebashi and Makoto Endo published their famous
review on ‘‘Calcium Ion and Muscle Contraction’’0006-291 2007 Elsevier Inc.
doi:10.1016/j.bbrc.2007.11.150
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Open access under CC BY license.[1]. It described their fundamental studies over at
least the previous 10 years demonstrating that cal-
cium ions were the regulatory signal controlling
muscular contraction. It also described the discov-
ery by Ebashi and his colleagues of the calcium
regulatory complex, troponin, on the actin ﬁla-
ments in vertebrate skeletal muscle. This work
was a major breakthrough in our understanding
of how contraction is regulated by Ca2+ in verte-
brate skeletal and cardiac muscles. Further elegant
studies by Ebashi [2] and a number of other groups
including those of Perry, Gergely, and Hartshorne
[3–5] established that the troponin complex was
composed of three components, troponin-C (TnC),
the subunit which binds the Ca2+, troponin-I
(TnI), the subunit that inhibits actin-myosin inter-
action and troponin-T (TnT) the tropomyosin bind-
ing subunit which binds the complex to the actin
ﬁlaments. Furthermore they demonstrated that
Ca2+ binding to TnC overcomes the inhibitory
eﬀect of TnI and thus acting as an ON/OFF switch
activates muscular contraction.
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mechanism in molluscan myosins [6] was a com-
plete surprise since up until then it was believed
that Ca2+ regulation of muscular contraction was
mediated solely by the troponin complex on the
actin thin ﬁlaments. However in molluscan muscles
it was shown that Ca2+ regulation of contraction
was mediated by Ca2+ binding directly to the myo-
sin and that the regulatory light chains located in
the ‘lever-arm’ or neck region of the myosin were
the regulatory subunits which under Ca2+ control
regulated myosin interaction with actin and thus
contraction in these muscles [6,7]. It was later dem-
onstrated that all myosins contain regulatory light
chains although those in vertebrate striated and
cardiac muscles do not serve as calcium regulatory
subunits [8].
(3) In the mid 1970s another Ca2+ regulatory mecha-
nism was identiﬁed in vertebrate smooth muscles
and non-muscle cells [9]. In these cells Ca2+ regu-
lates actin-myosin interaction indirectly by binding
to calmodulin, which activates a myosin light chain
kinase (MLCK) to phosphorylate the regulatory
light chains (RLCs) on the myosin. RLC phosphor-
ylation switches on the myosin so that it can interact
with actin to generate force and movement [10–12].
In non-muscle cells RLC phosphorylation may also
control the assembly of the myosin molecules into
ﬁlaments that are able to move and generate force
when interacting with actin [13]. At least in vitro
when the RLCs are non-phosphorylated these myo-
sins are monomeric and in a compact ‘‘switched oﬀ’’
folded state with their tails bent up next to their
motor domains and when their RLCs are phosphor-
ylated these myosin tails unfold and assemble into
ﬁlaments that are able to interact with actin ﬁla-
ments to generate force and movement [13].
Although we have not yet succeeded in demonstrat-
ing that this regulated myosin ﬁlament assembly
process occurs in vivo it is believed that such a mech-
anism is crucial for many cellular processes such as
assembling and disassembling the contractile ring
required for cytokinesis.
(4) In the mid 1990s it was shown that myosin existed as
a large superfamily of motor proteins [14–17] with
multiple functions and a possibly diverse range of
regulatory mechanisms. So far 24 distinct classes of
myosins have been identiﬁed [18]. In humans, 40
myosins belonging to 12 separate classes are
expressed [17]. Each class of myosin has a basic N-
terminal motor domain, RLCs or calmodulin sub-
units bound in the ‘‘neck’’ or lever-arm region and
tail domains that diﬀer widely in their size and struc-
ture. Unlike the myosins in muscle that form ﬁla-
ments and assemble into relatively stable sarcomeric
structures optimised for muscular contraction, the
‘new’ myosins do not assemble into ﬁlaments butare organised in a variety of ﬂexible actin cytoskele-
tal-membrane assembles optimised for their diverse
cellular functions [19].
In this review we have focused on the cellular functions
and possible regulatory mechanisms of one of these ‘new’
myosins, myosin VI. It is the only class of myosin that
moves towards the minus end of actin ﬁlaments [20] and
therefore appears to have unique functions in the cell.
Given the believed polarity of actin ﬁlaments in the cell
with their plus (barbed) ends inserted into or at membranes
and their minus (pointed) ends projecting inwards then
myosin VI would move cargo from the plasma membrane
into the cell and away from the surface of organelles such
as the Golgi complex. Myosin VI has been localised in
membrane ruﬄes at the leading edge of the cell, at the
Golgi complex, in clathrin coated pits/vesicles at the
plasma membrane, at the centrosome and in the midbody
during cytokinesis and has been implicated in a wide range
of processes such as endocytosis, exocytosis, maintenance
of Golgi morphology, cytokinesis and cell migration [21].
To begin to understand the role(s) that myosin VI plays
in these cellular events we will ﬁrst examine its structure
and in vitro properties.Domain structure and in vitro properties of myosin VI
Myosin VI is composed of the following basic myosin
domains: an N-terminal canonical 80 kDa motor domain
with an ATP binding pocket and actin binding interface,
a short neck or ‘lever-arm’ region with a single IQ domain
that binds a calmodulin, a tail with helical regions and a C-
terminal cargo binding domain [22]. Myosin VI also con-
tains a number of unique inserts: in the motor domain next
to the switch 1 loop beside the ATP binding pocket there is
a 22 amino acid insert that controls the nucleotide on and
oﬀ rates and is thus thought to ﬁne tune myosin VI for its
speciﬁc cellular functions [23] and between the motor
domain and ‘lever-arm’ region there is a 53 amino acid
insert that is the reverse gear responsible for the retrograde
movement of myosin VI along actin ﬁlaments [20]. Within
the tail region there are a large and small insert that gener-
ate four alternatively spliced myosin VI isoforms that are
diﬀerentially expressed and have distinct intracellular loca-
tions and functions [24,25].
High resolution structural analysis of the myosin VI
motor domain and lever-arm in the post-power stroke state
reveals a structure that is very similar to that of the motor
domains of the myosin IIs and Vs with the exception of the
two unique inserts [26]. The 53 amino acid insert is absent
in all other myosin classes and contains a novel motif that
binds a non-exchangeable calmodulin subunit [27]. This
insert is an integral part of the converter region that redi-
rects the lever-arm of myosin VI by 120o towards the minus
end of the actin ﬁlament thus allowing myosin VI to move
in the reverse direction along these ﬁlaments [26]. So far the
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solved.
Kinetic studies have shown that myosin VI has a high
aﬃnity for ADP and ADP release is the rate limiting step
in its ATPase cycle [28]. Thus myosin VI is a high duty
ratio motor protein and with a duty ratio of 0.8 it spends
most (80%) of its steady state ATPase cycle strongly
bound to actin [28]. Since it was believed that myosin VI
existed as a dimeric molecule on the basis of a predicted
coiled coil region in its tail region, most recent kinetic stud-
ies have used myosin VI constructs that have been dimer-
ised by the inclusion of a leucine zipper instead of the
C-terminal cargo binding tail domain [28–30] These engi-
neered artiﬁcial dimers, containing two motor domains,
have a high duty ratio and move processively along actin
ﬁlaments with an unexpectedly large step size of 30–
36 nm [31,32]. Like myosin V the two motor domains in
these myosin VI dimers appear to communicate with each
other (gating between the heads) so as to move processively
along an actin ﬁlament in a hand over hand fashion [33,34].
A number of possible models have been proposed toFig. 1. Myosin VI could function as a monomer or dimer or as both in the cell
region in yellow and cargo-binding domain (CBD) in blue) may associate with v
its CBD to PIP2 (red P) inserted in the membrane; or in (B) it could bind to
cytoplasmic tail of a membrane receptor; or (C) multiple monomers could bin
over the vesicle. As a dimer (D) the CBDs of two myosin VIs could dimerise wh
two myosin VIs bind to a dimeric binding partner (shown in brown) that is bexplain how gating might operate in these myosin VI
dimers [35]. However the observation that full-length
expressed and native myosin VI containing the crucial C-
terminal cargo binding region are monomers by biochemi-
cal and biophysical criteria and move non-processively
along actin ﬁlaments with single steps of 18 nm [36] ques-
tions the relevance of the work on the artiﬁcial dimers
and raises the intriguing proposal that myosin VI may exist
and function as a non-processive monomer and possibly as
a processive dimer in the cell? (Fig. 1).
The long step size achieved by myosin VI (30–36 nm for
the artiﬁcial dimer and 18 nm for the monomer) was unex-
pected since it has such a short lever-arm (maximum pre-
dicted length 10 nm)? It obviously cannot generate such a
large step using the conventional lever-arm mechanism
proposed for myosins II and V where the step size depends
in a linear fashion on the length of the lever-arm [37–39].
Although a working model has been proposed to explain
how a myosin VI dimer might be able to achieve such a
large step size [31], whether it exists as a stable dimer
in vivo, the overall conformation of the full-length molecule. Shown are a few possible ways how myosin VI (motor domain in red, tail
esicles and move them around the cell. As a monomer (A) it could bind via
a binding partner such as Dab2 (shown in green) that is bound to the
d via PIP2 molecules to the vesicle in clusters or distributed uniformly all
en bound to PIP2 molecules clustered on the vesicle surface or in (E) when
ound to a membrane receptor on a vesicle.
Fig. 2. A cartoon illustrating the positions of the potential regulatory sites in myosin VI. In the motor domain there is a 22 amino acid insert (275–297)
which regulates the ADP oﬀ rate and thus ATP binding to the ATPase site; a threonine at 405 in the actin binding interface which maybe phosphorylated
and involved in modulating interaction with actin and in the converter region, a unique 53 aa insert (761–814) that is the reverse gear, which determines the
direction that the myosin moves along an actin ﬁlament. The neck region contains a single IQ motif (in green) that binds a calmodulin, the regulatory
subunit that binds calcium. Just before the cargo-binding domain (CBD) there is a large insert (1036–1060) and within the CBD a small insert (1140–1148)
that generate four alternatively spliced isoforms that are diﬀerentially expressed and have distinct intracellular locations and functions. In the CBD, there
are two ‘hot spots’, the RRL and WWYmotifs, where all the so far characterised myosin VI binding partners bind (Table 1); also there are two threonines
(1092 and 1094) in the TINT sequence that can be phosphorylated and regulate the binding of optineurin to the CBD.
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how it is regulated are some of the properties that ﬁrst need
to be determined. Thus it is apparent that the ‘new’ classes
of unconventional myosins are extremely versatile multi-
domain motors in which inserts or domains can be added,
modiﬁed or exchanged to create ‘novel’ motor proteins
with unique properties capable of travelling towards the
minus or plus ends of actin ﬁlaments [40] (see Fig. 2).
Intracellular functions of myosin VI in mammalian cells
To illustrate the functional diversity of myosin VI, we
will focus on just three of its cellular functions; those which
have been studied in greatest detail:
Myosin VI and clathrin-mediated endocytosis
At the plasma membrane, endocytosis is the complex
process by which a cell is able to communicate with its
extracellular environment and involves the regulated
uptake of proteins, nutrients, receptors, and the retrieval
of membrane proteins and lipids lost after exocytosis.
Although clathrin mediated endocytosis is the best charac-
terised pathway, at least three other uptake pathways have
now been identiﬁed: macropinocytosis, caveolae-mediated
endocytosis and clathrin- and caveolae-independent endo-
cytosis [41,42]. Clathrin mediated endocytosis involves
the following basic sequence of steps: (i) cargo binds to
its receptor and clusters on the plasma membrane; (ii) a
pit forms containing these cargo-receptor complexes and
clathrin starts to assembles around it; (iii) the plasma mem-
brane invaginates to form a clathrin coated vesicle; (iv)
membrane ﬁssion occurs and the clathrin coated vesicle is
released into the cell where (v) the clathrin coat is removed
and the vesicle is transported towards its destination in thecell. Each step requires a vast assembly of structural coat
components and a host of accessory proteins that includes
actin cytoskeletal and motor proteins, which cooperate
together to drive the endocytic machinery [42–44].
So which speciﬁc steps in this complex process involves
myosin VI? The answer to this question appears to vary
depending on the type of cell being studied and myosin
VI isoform expressed [25,45]. For example in polarised epi-
thelial cells, the myosin VI isoform with the large insert in
the tail domain is concentrated in clathrin coated pits and
vesicles in the terminal web region just below the apical
plasma membrane [46,47]. At this apical surface Disabled
2 (Dab2), a myosin VI binding partner, co-localises with
myosin VI and since Dab2 binds to the cytoplasmic tails
of members of the LDLR family it links myosin VI to these
cell surface receptors [48]. So at the start of endocytosis,
myosin VI is ﬁrst recruited to the Dab2/LDL receptor
complex at the plasma membrane by binding to Dab2
and the signalling molecule PIP2 [49]. Given the polarity
of the actin ﬁlaments with their plus ends at the plasma
membrane and their minus ends pointing into the cell,
myosin VI being a minus end directed motor could move
the PIP2/Dab2/receptor complexes along the membrane
and cluster them to start to form a clathrin-coated pit.
Myosin VI could then generate the force required for ves-
icle formation by moving along these actin ﬁlaments and
by pulling in the membrane together with the host of struc-
tural coat and accessory proteins, a number of which sense
membrane curvature, could form a clathrin-coated pit/ves-
icle. By pushing polymerising actin ﬁlaments into the vesi-
cle neck in conjunction with accessory proteins like
dynamin, myosin VI could lead to vesicle scission and
could subsequently transport the clathrin-coated vesicle
into the actin rich terminal web region where it is uncoated.
In the ﬁnal stages the myosin VI isoforms with the small
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through the cortical actin ﬁlament network before they fuse
with the early endosome compartment [45]. Considerable
further work is needed to verify these speculations and
establish if and how myosin VI works in these speciﬁc steps
in endocytosis.
Myosin VI and exocytosis at the Golgi complex
The Golgi complex plays a central role in the protein
biosynthesis pathway in cells. Every protein synthesised
in the ER is transported to the Golgi complex, where it
undergoes post-translational modiﬁcation and is sorted
for delivery to either the cell surface or to an intracellular
compartment. In mammalian cells the Golgi complex occu-
pies a central perinuclear position organised around the
microtubule organising centre (MTOC) and consists of
stacks of ﬂattened membrane interconnected cisternae
which can be classiﬁed as the cis, medial, and trans-Golgi
compartments [50]. The cis- and trans-sides of the Golgi
complex are surrounded by an extensive network of mem-
brane tubules and vesicles; the cis-Golgi network (CGN)
and the trans-Golgi network (TGN). Proteins from the
ER enter the Golgi complex at the CGN, are passed
through the complex and are sorted and packaged into a
variety of diﬀerent vesicular carriers at the TGN for dis-
patch to diﬀerent cellular locations [51].
Myosin VI is present in vesicles at the Golgi complex
that are on average 200–400 nm away from the trans-side
of the Golgi complex [52,53]. In ﬁbroblasts from the
Snell’s waltzer myosin VI knock-out mouse the absence
of myosin VI leads to a 40% reduction in the size and
a collapse of the reticulate Golgi network structure and
a 40% reduction in protein secretion from the TGN to
the plasma membrane [53]. Both of these phenotypes
can be rescued by transfection and expression of full-
length myosin VI. So myosin VI interacting with the
actin cytoskeleton surrounding the Golgi complex could
be involved in maintaining the elaborate reticulate struc-
ture of the Golgi membranes. Whereas in the secretory
pathway myosin VI could also be involved in: (1) sorting
proteins into diﬀerent subdomains at the TGN for deliv-
ery to diﬀerent cellular compartments or (2) it could play
a role in vesicle formation and budding in analogy to its
proposed endocytic function at the plasma membrane or
(3) the short-range transport of cargo vesicles from the
TGN towards microtubules for their long distance trans-
port to the cell surface.
Myosin VI targeting to the Golgi complex and its
involvement in the secretory pathway requires binding
to one of its binding partners, optineurin [54] and the
small G-protein Rab8, which is involved in membrane
traﬃcking and has been identiﬁed as an optineurin bind-
ing partner [55]. In polarised epithelial cells to maintain
their highly polarised shape, specialised pathways have
evolved to sort and transport newly synthesised mem-
brane proteins from the Golgi complex to either the baso-
lateral or the apical surface depending on the type ofsorting motifs present in these proteins [56–58]. In pola-
rised MDCK cells the myosin VI isoform with no insert
in the tail domain is required for sorting and transport
of newly synthesised basolateral membrane proteins con-
taining the tyrosine-sorting motif to the basolateral
domain [47]. Since in polarised epithelial cells Rab8 acts
as a membrane anchor and regulates transport to the
basolateral domain [59,60] a functional transport complex
containing myosin VI, optineurin and Rab8 may operate,
since all three proteins are present in recycling endosomes,
which are the sorting station for basolateral transport in
MDCK cells [61].
Myosin VI and cell migration
A moving cell is polarised with a leading edge and a
trailing edge and the protrusive force for forward move-
ment is generated at the leading edge by the formation of
pseudopodia or lamellipoda coupled with cell adhesion
[62,63]. Identifying the role of myosin VI in cell migration
has acquired greater urgency with the discovery that myo-
sin VI is involved in cancer cell invasion [64]. So far the best
example for myosin VI’s role in cell motility is in border
cell migration in Drosophila ovaries, which has served as
a model for cancer cell invasion [65,66]. Myosin VI is cru-
cial for border cell migration and since it exists in a com-
plex with the adhesion proteins E-cadherin and b-catenin
it could by binding to stationary adhesion complexes in
the membrane develop a protrusive force by pushing the
actin ﬁlaments outwards thus moving the cell forwards
[65]. In mammalian cells less is known about myosin VI’s
role in cell motility although when stimulated with growth
factors, myosin VI is actively recruited into membrane ruf-
ﬂes at the leading edge of these moving cells and is phos-
phorylated in the motor domain [52]. It has been
suggested that in these cells F-actin polymerisation coupled
with membrane insertion and cell adhesion generates the
protrusive force at the front end of the cell to push the
plasma membrane outwards [62]. Thus at the leading edge
of the cell it is likely that the following processes drive cell
migration: (1) polymerisation/depolymerisation of the
actin ﬁlament network regulated by the Arp2/3 complex
and the Rho GTPases [67,68] followed by the subsequent
remodelling of the cortical actin cytoskeleton; (2) the
assembly of adhesion protein complexes at the membrane
and their adhesion to the substrate [69]; (3) the transport
of new membrane and its insertion into the leading edge
[52]; and (4) the development of protrusive force by motor
proteins such as the myosins I, V, and VI interacting with
the actin ﬁlaments and the stationary adhesion complexes
in the membrane. In addition myosin VI together possibly
with other myosins such as myosins Vs and Is are likely to
be involved in the delivery of adhesion molecules and addi-
tional membrane to the leading edge of the moving cell.
So having brieﬂy reviewed myosin VI’s possible roles in
a number of basic cellular functions we will now discuss
potential mechanisms how myosin VI’s involvement in
these processes maybe regulated.
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Although relatively little is known about how myosin VI
is regulated, multiple regulatory mechanisms are likely to
be involved, acting in concert to modulate the activity of
myosin VI rather than acting as an ON/OFF switch like
the Ca2+ regulatory mechanisms that operate in muscle
[21]. Since myosin VI is involved in such a wide variety
of cellular functions it must be tightly regulated so that it
is only active where and when it is required in the cell.
For the cell to maintain its organisation and the correct dis-
tribution of components the activities of all the motor pro-
teins involved must be tightly regulated and coordinated.
Understanding how myosin VI is regulated has importance
for developing therapeutic targets for combating human
diseases such as cancer, deafness and cystic ﬁbrosis. Possi-
ble myosin VI regulatory mechanisms include:
Expression of alternatively spliced isoforms due to inserts in
the tail domains
At the basic level of regulation myosin VI is expressed in
a cell speciﬁc fashion as four alternatively spliced isoforms
with a large (21–31 aa), or a small (9 aa), or both or no
inserts in the tail region [70]. In polarised epithelial cells
the myosin VI isoform with the large insert is localized at
the apical surface where it is involved in clathrin-mediated
endocytosis, whereas the myosin VI isoform with no inserts
is localized to the trans-side of the Golgi complex and to
recycling endosomes where it plays a role in the sorting
and delivery of speciﬁc cargo to the basolateral surface
[47]. How the presence or absence of these inserts in the tail
inﬂuences the functions and intracellular targeting of myo-
sin VI is not known. Since neither of the tail inserts contain
any obvious structural motifs nor apparent binding sites
they may control the overall conformation of the myosin
VI molecule and thus possibly its binding to speciﬁc bind-
ing partners.
Phosphorylation of potential sites in the motor domain and
tail region
When A431 (a human epithelial carcinoma cell line) cells
are stimulated with epidermal growth factor (EGF) myosin
VI is recruited into the dynamic ruﬄing membrane at the
leading edge and there is a fourfold increase in the level
of myosin VI phosphorylation [52]. It was suggested that
threonine (T406) in the hypotrophic cardiomyopathy loop
in the actin binding region in the motor domain might be
the residue phosphorylated and that PAK1, a Rac-, and
cdc42-activated kinase, might be the kinase responsible.
This T406 residue obeys the TEDS rule (it must be either
a Thr, Glu, Asp or Ser) for myosin motor domain phos-
phorylation sites proposed by Bement and Mooseker [71].
Phosphorylation of this threonine residue in the motor
domains of Acanthamoeba myosins IA and IB is required
for maximal actin-activated ATPase activity [72], howeverin myosin VI phosphorylation of T406 does not alter its rate
of actin ﬁlament sliding or its maximal actin-activated
ATPase rate [29]. Although T406 phosphorylation has no
apparent eﬀect on myosin VI’s in vitro kinetic properties,
in the cell it is possible that it may have a rather more sub-
tle role modulating myosin VI-actin cytoskeletal interac-
tions [52,73]. In the C-terminal region of the myosin VI
tail two sites (T1089INT1092) phosphorylated by PAK3 have
been identiﬁed by mass spectrometry and phosphorylation
at these threonine residues has been shown to regulate opti-
neurin binding to the myosin VI tail [54]. Interestingly
phosphorylation at these sites does not regulate myosin
VI binding to any of the other binding partners so far
tested.
So far the kinases that have been tested on myosin VI
are members of the PAK family, which exist as a number
of isoforms with speciﬁc domains that target them to spe-
ciﬁc cellular locations. LMTK2 (Lemur tyrosine kinase2)
was recently identiﬁed as a myosin VI binding partner,
but so far it has not been demonstrated that it phosphory-
lates myosin VI [74]. It is possible that myosin VI acts as a
transporter to carry LMTK2 to speciﬁc sites in the cell,
where its phosphorylation target proteins are located. Thus
trying to piece together the roles of myosin VI phosphory-
lation in both the motor and tail domains in a speciﬁc and
temporal manner within the cell will be diﬃcult but will be
necessary to understand how these myosin VI regulatory
systems operate.
Ca2+ binding to the calmodulin subunit in the lever-arm
region
Myosin VI has a short lever-arm with a single IQ motif
that binds calmodulin but very little is known about how
calcium binding to this calmodulin aﬀects the structure
and intracellular functions of the myosin. Although the
unique insert (reverse gear) in the converter region, also
contains a bound calmodulin, it appears that this calmod-
ulin plays a structural role and its bound calcium is
non-exchangeable [27]. Increases in Ca2+ concentration
however do alter the in vitro kinetic properties of myosin
VI; both the rate of ADP release and velocity of acto-myo-
sin VI motility are reduced and in an artiﬁcial myosin VI
dimer construct there is a signiﬁcant decrease in processive
movement [29]. Calcium also appears to be required for the
binding of full-length myosin VI to liposomes [49] (see next
section).
Binding to phosphoinositides (PIP2) in the plasma
membrane binding
Myosin VI binds to liposomes, speciﬁcally those con-
taining the second messenger PtdIns(4,5)P2 (PIP2) [49].
The PIP2 binding site is in the C-terminal cargo binding tail
region (CBD) and consists of a mix of basic residues (R/K)
alternating with hydrophobic residues, very similar to the
regions identiﬁed in other cytoskeletal PIP2-binding pro-
F. Buss, J. Kendrick-Jones / Biochemical and Biophysical Research Communications 369 (2008) 165–175 171teins [75]. How calcium binding to the calmodulin in the
lever-arm controls PIP2 binding to the CBD is not known
but it would suggest that major conformational changes in
the myosin VI molecule may be involved (see next section).
The myosin VI tail binds to PIP2 containing liposomes with
high aﬃnity (Kd = 0.3 lm) and when bound there is a
major change (a 31% increase in a-helicity) in the second-
ary structure of the tail. In HeLa cells mutation of the
PIP2 binding site reduces the targeting of full-length myo-
sin VI and its tail to clathrin-coated structures by about
50% [49]. PIP2 is the major polyphosphoinositide in mam-
malian cells and acts as a second messenger and membrane
anchor and is important for the attachment of the cytoskel-
eton to the plasma membrane, and for endocytosis, exocy-
tosis and membrane traﬃcking. It recruits many
cytoskeletal and endocytic proteins to the plasma mem-
brane and regulates the assembly, scission and uncoating
of clathrin-coated vesicles [76–78]. PIP2 is non-uniformly
distributed in the plasma membrane and is concentrated
at active sites of clathrin-mediated endocytosis where it
may recruit the adaptor Dab2, myosin VI and accessory/
cytoskeletal proteins to the membrane at the initiation of
clathrin-coated pit assembly.Structural changes controlling the conformation of myosin
VI
A number of proteins bind to the C-terminal domain in
myosin VI (see ‘‘A monomer/dimer equilibrium’’ and
Table 1) and a mechanism to regulate their binding is
essential. Major conformational changes in the tail could
be used to regulate/block these protein–protein interac-
tions. For example non-muscle myosin IIs and myosin V
can exist in vitro in a folded inactive state, with the tails
interacting with the heads, regulated either by regulatory
light chain phosphorylation or by calcium binding to cal-
modulin [13,79,80]. However whether these myosins exist
in folded states in cells is yet to be established. So far there
is no conclusive proof that myosin VI can exist as a folded
molecule but its tail contains extensive regions which are
predicted to be unstructured by multiple secondary struc-
ture prediction algorithms (performed using the
NPS@.Network Protein Sequence Analysis web server)
([81] and there are helical regions with hinges that mightTable 1
Myosin VI binding partners: their cellular locations, binding sites on myosin
Binding
partner
Cellular location Binding
site
Dab2 Plasma membrane, clathrin-coated pits and
vesicles
WWY
Optineurin Cytoplasmic vesicles, Golgi complex RRL
GIPC Endocytic vesicles, Golgi region RRL
SAP97 Neuronal synaptic sites, cell adhesion sites Unknown
T6BP/NDP52 Vesicles in perinuclear Golgi region, focal
adhesions
RRL
LMTK2 Cytoplasmic vesicles, Golgi region WWYalso allow the tail to fold. Single molecule imaging studies
show that myosin VI is a monomer and the tail is ﬂexible;
for example, in the absence of nucleotide, the tail is bent
and lies next to the motor domain whereas in the presence
of ATP the tail is straight [36]. Cellular localisation studies
on myosin VI [52] support the idea that myosin VI may
exist in an ‘inactive’ state in the cell since they show that
a considerable proportion of the endogenous myosin VI
is present as a diﬀuse cytoplasmic pool not associated with
any obvious cellular compartments or structures. One
envisages that in this cytoplasmic pool, myosin VI is in a
folded inactive state with the binding sites on the CBD
for its binding partners masked and the actin interface on
the motor domain blocked and phosphorylation or
increases in Ca2+ concentration and/or binding to cargo
or membrane would activate the molecule.A monomer/dimer equilibrium
Myosin VI may function as both a non-processive
monomer and a processive dimer depending on the cell’s
requirements and controlling such a monomer–dimer equi-
librium could be an important regulatory mechanism (see
Fig. 1). One can imagine that for certain cellular functions
such as maintaining tension, clustering transmembrane
receptors or tethering vesicles to actin ﬁlaments, a non-pro-
cessive monomer would operate whereas for retrograde
transport of vesicles along actin ﬁlaments, processive
dimers would be preferred. In vitro full-length myosin VI
is a monomer however it can be induced to form a few
dimers (17%) when clustered on actin ﬁlaments [82]. Many
of myosin VI’s binding partners contain regions of pre-
dicted coiled coil and leucine zippers and there is prelimin-
ary evidence that one of them forms stable dimers [83].
Myosin VI binding to such a stable dimeric binding partner
could then operate as a processive dimer. When the myosin
VI C-terminal domain binds to liposomes it can be cross-
linked to form dimers [49]. This is similar to the kinesin
motor KIF1A/Unc104, which also dimerises upon lipo-
some binding and the resulting dimer is able to transport
the liposome processively along microtubules [84]. If myo-
sin VI is involved in vesicular traﬃcking then it has been
speculated that dimerisation on the surface of a vesicle or
when clustered on actin ﬁlaments or when bound to speciﬁcVI and proposed function
Proposed function
Endocytosis of LDLR, tumour suppressor signalling pathways cell
adhesion & movement
Exocytosis/secretion, Golgi morphology
Endocytosis, receptor traﬃcking at Golgi, cell migration, cytokinesis
Traﬃcking and endocytosis of AMPA receptors, cell-cell adhesion
Secretion, cell signalling, cell adhesions and ruﬄing
Serine/threonine kinase endocytic recycling
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port motor [85,86] (Fig. 1). It is however very much a mat-
ter of debate whether dimer molecules are more eﬃcient
than multiple monomers in moving a 100nm vesicle
through the highly cross-linked cortical actin network
below the plasma membrane. However whether myosin
VI exists and functions in the cell as a monomer and/or
dimer and whether this process might act as a novel regu-
latory mechanism remains to be established.
Binding to speciﬁc adaptors and binding partners
A number of binding partners that target/recruit myosin
VI to speciﬁc intracellular locations and regulate/determine
its functions have now been identiﬁed by yeast-2-hybrid
screens, mammalian-2-hybrid assays and by a series of
in vitro and in vivo binding assays (see Table 1). Four of
them are brieﬂy described here:
Disabled-2 (Dab2) is a 96-kDa protein, which is
thought to be a speciﬁc adaptor for members of the
Low Density Lipoprotein receptor (LDLR) family.
Dab2 has a N-terminal phosphotyrosine domain that
interacts not only with the internalisation signal in the
cytoplasmic tail of LDLR receptors [87], but also simulta-
neously with phosphoinositides such as PIP2 thus attach-
ing it to the plasma membrane [88]. Dab2 also binds to
the adaptor protein AP2, to clathrin, to speciﬁc endocytic
accessory proteins such as Eps 15 and to myosin VI
[48,89]. Thus, Dab2 plays a key role in clathrin-mediated
endocytosis by acting as a cargo speciﬁc adaptor protein
which sorts and links membrane receptors to the endo-
cytic machinery at the plasma membrane. Myosin VI
co-localises with Dab2 in clathrin coated pits and vesicles
in the apical domain of polarised cells suggesting that
together they are involved in the early stages of clathrin
mediated endocytosis such as receptor clustering and
coated pit formation [48,45,49].
Optineurin; FIP-2; NRP (Nemo Related Protein) is a
67-kDa protein with predicted coiled coil regions, two leu-
cine zipper domains and a putative Zn ﬁnger [90]. Optineu-
rin binds to Huntingtin, the large protein involved in the
neurodegenerative disorder, Huntington’s disease [91] and
to Rab8, a small GTPase implicated in vesicular transport
from the trans-Golgi network to the plasma membrane
[55]. Optineurin and Rab8 link myosin VI to the Golgi
complex and together they are responsible for maintaining
the Golgi ribbon-like structure and for secretion from the
Golgi to the plasma membrane [54].
GIPC (homologous to GLUT1 C-terminal-binding pro-
tein, SEMCAP-1 and synectin) binds to a number of trans-
membrane receptors such as the LDL receptor megalin
[92], the human lutropin receptor (LHR) [93] and the b-1
adrenergic receptor [95] and it is likely that myosin VI
and GIPC are involved in the endocytosis of these recep-
tors [96]. The myosin VI-small or no insert isoforms co-
localise with GIPC in uncoated endocytic vesicles and
appear be involved in their movement through the corticalactin ﬁlament network below the plasma membrane
[45,97].
SAP97 (postsynaptic density-95 protein) contains three
PDZ domains (protein interaction domains), a SH3
domain (src homology 3) and a region with a guanylate
kinase like sequence [98]. It binds to the Glu1 subunit of
AMPA-type glutamate receptors in synapses and may have
a role in the traﬃcking of AMPA receptors to the plasma
membrane [99,100]. SAP97 interacts with myosin VI and
immunoprecipitates as a complex from neuronal cells
together with myosin VI and GluR1 [101]. Myosin VI
may be involved in the clathrin-mediated endocytosis of
AMPA receptors or in the exocytic transport or recyling
of AMPA receptors to the cell surface and its absence in
the Snell’s waltzer knock-out mouse leads to defects in syn-
aptic structure and astrogliosis [102].
These binding partners all bind to two ‘hot spots’ either
the RRL or WWY speciﬁc sites on the C-terminal cargo
binding tail domain (Table 1) and may thus regulate the
functions of myosin VI by helping to unfold and stabilise
the tail and by recruiting the activemolecule to speciﬁc intra-
cellular locations [49]. The mutation of hydrophobic resi-
dues W to L in the Dab2 binding site (WWY to WLY)
abolishes Dab2 binding to myosin VI indicating that the
binding is relatively weak and probably transient. This bind-
ing aﬃnity however maybe increased by binding to PIP2 [49]
andother endocytic proteins. Lowaﬃnity bindingmotifs are
present in endocytic proteins [103] and it has been suggested
that low aﬃnity protein-protein interactions are essential for
the rapid and accurate coordination between the vast range
of components involved in membrane traﬃcking pathways
such as endocytosis [104,105].
Inserts in the motor domain
Myosin VI has two unique inserts in its motor domain
(head) not present in any other class of myosin, that regu-
late motor activity and directionality of movement along
actin ﬁlaments. One insert (22 aa) near the switch 1 loop
in the ATP binding region greatly decreases the ADP oﬀ
rate and thus slows the rate of ATP rebinding [26]. It has
been postulated that if myosin VI functions as a processive
dimer then slower ATP rebinding would mean that the lead
head would remain attached to actin for a longer time thus
allowing mechanical coordination (gating) between the two
heads to occur, which is essential for processive movement
[23]. The second insert (53 aa) is an integral part of the con-
verter region in myosin VI and contains a uniquely bound
calmodulin [26,20,27]. It has recently been conclusively
demonstrated that this insert is the sole determinant
responsible for the reverse movement exhibited by myosin
VI [106,107]. If this insert is missing then myosin VI moves
like all the other myosins towards the plus end of actin ﬁl-
aments. Since this insert, called the reverse gear, is absent
in all the other myosins expressed in mammalian cells, it
means that no other myosin is able to move in the minus
end direction on actin at least using such a reverse gear
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myosin VI, able to survive? What other motor proteins,
mechanisms or pathways are able to compensate for the
absence of myosin VI? Answers to these and many other
intriguing questions may soon be forthcoming.Conclusions
Establishing precisely the mechanisms how myosin VI
functions and is regulated in the many processes it is
involved in diﬀerent cells will help our understanding
how it may operate in diseases such as cancer and deafness
and will we hope aid in the development of intervention
strategies and the identiﬁcation of potential drug targets.
The multiple functions of the unique retrograde motor
myosin VI appear to be regulated in a number of ways;
for example by the presence or absence of inserts in both
the tail and motor domains, by PIP2/liposome binding,
by phosphorylation, by calcium binding, by binding part-
ners and possibly by other signals and modiﬁcations, which
may together modulate its functions in the cell. In addition
for speciﬁc functions such as anchoring or tethering myosin
VI may operate as a monomer, whereas in traﬃcking path-
ways it may function as a dimer or as raft of monomers. Its
assembly state may also be determined by the speciﬁc myo-
sin VI isoform expressed, by the type of cell, e.g., polarised
versus non-polarised, and by the nature and organisation
of the cytoskeletal architecture in which it needs to func-
tion. Furthermore myosin VI does not operate in isolation
and a host of other myosins, microtubule motors and spe-
ciﬁc binding partners are also likely to regulate its func-
tions. Answers to these and many more basic questions
need to be established before a full picture emerges of
how myosin VI functions and is regulated in cells.References
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